Patients have a new, safe, and effective way to improve how their chin projects – without undergoing invasive surgery. Restylane® Defyne is now FDA approved for the treatment of “mild to moderate chin retrusion” among adults aged 22 and older. Khrom Dermatology and Aesthetics in Brooklyn, NY is pleased to offer this smooth, Hyaluronic Acid (HA)-based filler to bring balance to the “anchor” of the face, elevating overall facial attractiveness.
The filler is engineered to move with facial expressions for a natural result. Galderma Laboratories reported 99% of patients had improved chin projection at 12 weeks, while 96% of injectors said patients’ improvements persisted for up to a year. More than 2.5 million Restylane® Defyne treatments have been administered worldwide to correct moderate to severe mid-to-lower face folds since 2010 when the filler was first available (outside of the U.S). Read the full article here
Share this Article
Back to In the Press Page
